| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 3 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9ABZ7
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.596 |
| CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.597 |
| CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.593 |
| CLV_PCSK_KEX2_1 | 199 | 201 | PF00082 | 0.580 |
| CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.616 |
| CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.626 |
| CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.573 |
| CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.649 |
| CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.592 |
| CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.525 |
| DEG_APCC_DBOX_1 | 76 | 84 | PF00400 | 0.495 |
| DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.604 |
| DOC_CYCLIN_yCln2_LP_2 | 105 | 108 | PF00134 | 0.432 |
| DOC_PP2B_LxvP_1 | 104 | 107 | PF13499 | 0.389 |
| DOC_PP4_FxxP_1 | 115 | 118 | PF00568 | 0.336 |
| DOC_PP4_FxxP_1 | 203 | 206 | PF00568 | 0.365 |
| DOC_USP7_MATH_1 | 125 | 129 | PF00917 | 0.416 |
| DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.440 |
| DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.712 |
| DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.444 |
| LIG_14-3-3_CanoR_1 | 53 | 58 | PF00244 | 0.376 |
| LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.370 |
| LIG_14-3-3_CanoR_1 | 82 | 90 | PF00244 | 0.459 |
| LIG_APCC_ABBA_1 | 204 | 209 | PF00400 | 0.429 |
| LIG_BRCT_BRCA1_1 | 108 | 112 | PF00533 | 0.409 |
| LIG_BRCT_BRCA1_1 | 88 | 92 | PF00533 | 0.494 |
| LIG_eIF4E_1 | 91 | 97 | PF01652 | 0.397 |
| LIG_EVH1_2 | 107 | 111 | PF00568 | 0.374 |
| LIG_FHA_1 | 100 | 106 | PF00498 | 0.404 |
| LIG_FHA_1 | 210 | 216 | PF00498 | 0.403 |
| LIG_FHA_1 | 5 | 11 | PF00498 | 0.703 |
| LIG_FHA_2 | 196 | 202 | PF00498 | 0.466 |
| LIG_FHA_2 | 67 | 73 | PF00498 | 0.375 |
| LIG_LIR_Apic_2 | 148 | 154 | PF02991 | 0.293 |
| LIG_LIR_Apic_2 | 201 | 206 | PF02991 | 0.377 |
| LIG_LIR_Gen_1 | 152 | 163 | PF02991 | 0.391 |
| LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.349 |
| LIG_LIR_Nem_3 | 148 | 153 | PF02991 | 0.361 |
| LIG_MLH1_MIPbox_1 | 108 | 112 | PF16413 | 0.421 |
| LIG_MLH1_MIPbox_1 | 88 | 92 | PF16413 | 0.494 |
| LIG_Pex14_2 | 111 | 115 | PF04695 | 0.349 |
| LIG_SH2_CRK | 151 | 155 | PF00017 | 0.293 |
| LIG_SH2_NCK_1 | 151 | 155 | PF00017 | 0.376 |
| LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.306 |
| LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.348 |
| LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.388 |
| LIG_SH3_3 | 164 | 170 | PF00018 | 0.358 |
| LIG_SH3_3 | 22 | 28 | PF00018 | 0.537 |
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.402 |
| LIG_SH3_3 | 7 | 13 | PF00018 | 0.702 |
| LIG_SUMO_SIM_anti_2 | 229 | 235 | PF11976 | 0.403 |
| LIG_SUMO_SIM_par_1 | 229 | 235 | PF11976 | 0.446 |
| LIG_TRAF2_1 | 132 | 135 | PF00917 | 0.378 |
| LIG_UBA3_1 | 36 | 41 | PF00899 | 0.475 |
| MOD_CK1_1 | 19 | 25 | PF00069 | 0.505 |
| MOD_CK1_1 | 5 | 11 | PF00069 | 0.679 |
| MOD_CK2_1 | 117 | 123 | PF00069 | 0.417 |
| MOD_CK2_1 | 195 | 201 | PF00069 | 0.444 |
| MOD_GlcNHglycan | 17 | 21 | PF01048 | 0.530 |
| MOD_GlcNHglycan | 188 | 192 | PF01048 | 0.623 |
| MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.615 |
| MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.642 |
| MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.672 |
| MOD_GSK3_1 | 113 | 120 | PF00069 | 0.397 |
| MOD_GSK3_1 | 145 | 152 | PF00069 | 0.387 |
| MOD_GSK3_1 | 210 | 217 | PF00069 | 0.336 |
| MOD_GSK3_1 | 58 | 65 | PF00069 | 0.351 |
| MOD_LATS_1 | 51 | 57 | PF00433 | 0.424 |
| MOD_N-GLC_1 | 86 | 91 | PF02516 | 0.682 |
| MOD_NEK2_1 | 145 | 150 | PF00069 | 0.285 |
| MOD_NEK2_1 | 195 | 200 | PF00069 | 0.440 |
| MOD_NEK2_1 | 86 | 91 | PF00069 | 0.442 |
| MOD_NEK2_1 | 97 | 102 | PF00069 | 0.333 |
| MOD_PKA_1 | 62 | 68 | PF00069 | 0.358 |
| MOD_PKA_1 | 76 | 82 | PF00069 | 0.415 |
| MOD_PKA_2 | 62 | 68 | PF00069 | 0.358 |
| MOD_PKA_2 | 76 | 82 | PF00069 | 0.415 |
| MOD_Plk_1 | 86 | 92 | PF00069 | 0.461 |
| MOD_Plk_4 | 107 | 113 | PF00069 | 0.392 |
| MOD_Plk_4 | 145 | 151 | PF00069 | 0.358 |
| MOD_Plk_4 | 5 | 11 | PF00069 | 0.609 |
| MOD_Plk_4 | 53 | 59 | PF00069 | 0.323 |
| MOD_Plk_4 | 62 | 68 | PF00069 | 0.358 |
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.445 |
| TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.384 |
| TRG_DiLeu_BaEn_1 | 229 | 234 | PF01217 | 0.371 |
| TRG_DiLeu_BaLyEn_6 | 100 | 105 | PF01217 | 0.440 |
| TRG_ER_diArg_1 | 75 | 77 | PF00400 | 0.502 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PDU2 | Leptomonas seymouri | 75% | 100% |
| A0A0S4JQK8 | Bodo saltans | 34% | 90% |
| A0A1X0P2T1 | Trypanosomatidae | 47% | 99% |
| A0A3S5ISA4 | Trypanosoma rangeli | 49% | 100% |
| A0A451EJ66 | Leishmania donovani | 94% | 100% |
| A4H323 | Leishmania braziliensis | 88% | 100% |
| A4HRC9 | Leishmania infantum | 95% | 100% |
| C9ZXG7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 89% |
| E9AJ94 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
| V5B2Q8 | Trypanosoma cruzi | 48% | 91% |